Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear members of the Canadian Biomaterials Society, We are inviting you today to a Conference Series that is being organized by the BioEngineering and Therapeutic Solutions BEaTS Laboratory, in partnership with the Ottawa Student Chapter of the CBS CBS-OSC , the University of Ottawa, the University of Ottawa Heart Institute, and the University of Toronto...

CALL FOR ABSTRACTS Dear members and friends of the Canadian Biomaterials Society, The 36th Annual General Meeting, hosted by the University of Waterloo, will be held from May 13th to May 15th on Hopin, a virtual conference platform...

Dear friends, The organizing committee of the 36th annual conference of the Canadian Biomaterials Society is pleased to inform you that the Call for Abstracts will be issued in early January...

On behalf of the Canadian Biomaterials Society - Southwestern Ontario Student Chapter, we re excited to announce the first official rescheduled CBS-SWOSC Research Symposium We re reaching out to you to potentially submit an abstract for either an oral presentation, virtual poster, or 3 Minute Thesis-style presentation...

Breast cancer metastasis to bone is associated with poor patient prognosis as current non-specific therapeutics are administered systemically with deleterious side effects...

Protein adsorption is an initial response to biomaterials and a precursor to thrombus formation and inflammation, which can result in significant challenges to device efficacy...

Recent efforts from the scientific community have focused on the development of in vitro systems that recapitulate key components of the complex architecture of tissues and organ functions, showing tremendous potential for disease modelling as well as drug development and discovery...

Osteoclasts play an important role in bone remodelling process1. An in vitro assay that could assess the functions of osteoclasts, is critical for understanding the process of bone resorption and the effectiveness of anti-osteoporotic drugs...

Systemic adoptive T lymphocyte transfer is an emerging cancer immunotherapy showing tremendous promise in clinical studies, and its success lies in the ability of the antigen-experienced cytotoxic T lymphocytes cTL to access and to persist in the tumour microenvironment 1 ...